• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏基质在良性和恶性胆道疾病中的作用。

Liver Matrix in Benign and Malignant Biliary Tract Disease.

机构信息

Department of Molecular Medicine, University of Padua, Padua, Italy.

Liver Center, Department of Medicine, Yale University, New Haven, Connecticut.

出版信息

Semin Liver Dis. 2020 Aug;40(3):282-297. doi: 10.1055/s-0040-1705109. Epub 2020 Mar 11.

DOI:10.1055/s-0040-1705109
PMID:32162285
Abstract

The extracellular matrix is a highly reactive scaffold formed by a wide array of multifunctional molecules, encompassing collagens and noncollagenous glycoproteins, proteoglycans, glycosaminoglycans, and polysaccharides. Besides outlining the tissue borders, the extracellular matrix profoundly regulates the behavior of resident cells by transducing mechanical signals, and by integrating multiple cues derived from the microenvironment. Evidence is mounting that changes in the biostructure of the extracellular matrix are instrumental for biliary repair. Following biliary damage and eventually, malignant transformation, the extracellular matrix undergoes several quantitative and qualitative modifications, which direct interactions among hepatic progenitor cells, reactive ductular cells, activated myofibroblasts and macrophages, to generate the ductular reaction. Herein, we will give an overview of the main molecular factors contributing to extracellular matrix remodeling in cholangiopathies. Then, we will discuss the structural alterations in terms of biochemical composition and physical stiffness featuring the "desmoplastic matrix" of cholangiocarcinoma along with their pro-oncogenic effects.

摘要

细胞外基质是一种由多种多功能分子形成的高度反应性支架,包括胶原和非胶原糖蛋白、蛋白聚糖、糖胺聚糖和多糖。除了勾勒出组织边界外,细胞外基质还通过传递机械信号,以及整合来自微环境的多种信号,深刻地调节常驻细胞的行为。越来越多的证据表明,细胞外基质的生物结构变化对胆管修复至关重要。在胆管损伤后,最终发生恶性转化后,细胞外基质经历了几种数量和质量上的改变,这些改变指导肝祖细胞、反应性胆管细胞、激活的肌成纤维细胞和巨噬细胞之间的相互作用,从而产生胆管反应。在此,我们将概述导致胆管疾病中细胞外基质重塑的主要分子因素。然后,我们将讨论“纤维母细胞性基质”的生化组成和物理硬度方面的结构改变及其致癌作用。

相似文献

1
Liver Matrix in Benign and Malignant Biliary Tract Disease.肝脏基质在良性和恶性胆道疾病中的作用。
Semin Liver Dis. 2020 Aug;40(3):282-297. doi: 10.1055/s-0040-1705109. Epub 2020 Mar 11.
2
Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.与纤维化基质微环境相关的慢性胆管损伤在p53基因缺陷小鼠中引发胆管癌。
Cancer Res. 2006 Jul 1;66(13):6622-7. doi: 10.1158/0008-5472.CAN-05-4609.
3
Role of Immune Cells in Biliary Repair.免疫细胞在胆管修复中的作用。
Front Immunol. 2022 Mar 30;13:866040. doi: 10.3389/fimmu.2022.866040. eCollection 2022.
4
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.胆管癌中肿瘤上皮与基质之间的有害相互作用。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1435-1443. doi: 10.1016/j.bbadis.2017.07.028. Epub 2017 Jul 27.
5
Emerging concepts in biliary repair and fibrosis.胆道修复与纤维化的新观念
Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G102-G116. doi: 10.1152/ajpgi.00452.2016. Epub 2017 May 19.
6
[Inflammatory and neoplastic cholangiopathies.].[炎症性和肿瘤性胆管病。]
Recenti Prog Med. 2018 Dec;109(12):595-599. doi: 10.1701/3082.30744.
7
Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.表达致癌 KRAS 的类器官具有胆管上皮干细胞特性,可在小鼠中引发胆管癌。
Cancer Sci. 2021 May;112(5):1822-1838. doi: 10.1111/cas.14703. Epub 2021 Mar 8.
8
Development and molecular composition of the hepatic progenitor cell niche.肝祖细胞微环境的发育与分子组成
Dan Med J. 2013 May;60(5):B4640.
9
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.肝脏良性胆管病变的组织病理学:肝内胆管癌的形态学模仿者还是前驱病变?
Clin Mol Hepatol. 2016 Sep;22(3):400-405. doi: 10.3350/cmh.2016.0105.
10
Case of an extra-large biliary intraductal papillary neoplasia.一例特大胆管内乳头状瘤病例。
BMJ Case Rep. 2019 Nov 19;12(11):e233150. doi: 10.1136/bcr-2019-233150.

引用本文的文献

1
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer.肝癌中肝星状细胞的功能异质性
Semin Liver Dis. 2025 Mar;45(1):33-51. doi: 10.1055/a-2551-0724. Epub 2025 Mar 5.
2
Tumor microenvironment and immunology of cholangiocarcinoma.胆管癌的肿瘤微环境与免疫学
Hepatoma Res. 2022;8. doi: 10.20517/2394-5079.2021.140. Epub 2022 Mar 10.
3
Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities.门脉纤维化与小胆管反应:在肝病进展中的病理生理作用及转化机遇
Gastroenterology. 2025 Apr;168(4):675-690. doi: 10.1053/j.gastro.2024.07.044. Epub 2024 Sep 7.
4
A Complex Interplay of Tumor Microenvironment Could Enhance Cholangiocarcinoma Progression Even After Surgery: A Prospective Study.肿瘤微环境的复杂相互作用即使在手术后也可能促进胆管癌进展:一项前瞻性研究
J Clin Med Res. 2024 Aug;16(7-8):363-374. doi: 10.14740/jocmr5201. Epub 2024 Jul 23.
5
Advances in targeted therapy of cholangiocarcinoma.胆管癌的靶向治疗进展。
Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15.
6
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.上调的 LAMA3 调节胆管癌细胞的增殖、黏附、迁移和上皮-间充质转化。
Sci Rep. 2023 Dec 18;13(1):22598. doi: 10.1038/s41598-023-48798-8.
7
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.肝细胞癌中的细胞外基质:机制与治疗弱点。
Cell Rep Med. 2023 Sep 19;4(9):101170. doi: 10.1016/j.xcrm.2023.101170. Epub 2023 Aug 30.
8
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.代谢综合征患者肝内胆管癌的特征是肿瘤基质中骨桥蛋白过表达。
Int J Mol Sci. 2023 Mar 1;24(5):4748. doi: 10.3390/ijms24054748.
9
Cholangiocarcinoma.胆管癌。
Nat Rev Dis Primers. 2021 Sep 9;7(1):65. doi: 10.1038/s41572-021-00300-2.
10
New insights on the role of vascular endothelial growth factor in biliary pathophysiology.血管内皮生长因子在胆汁病理生理学中作用的新见解。
JHEP Rep. 2021 Feb 4;3(3):100251. doi: 10.1016/j.jhepr.2021.100251. eCollection 2021 Jun.